BDBM621885 (S)-N-((R or S)-3- chloro-4-(trifluoro- methoxy)phenyl)(2- (trifluoromethyl) pyrimidin-4-yl)methyl)- 2-oxoimidazolidine-4- carboxamide::US20230312528, Example 49B

SMILES FC(F)(F)Oc1ccc(cc1Cl)[C@@H](NC(=O)[C@@H]1CNC(=O)N1)c1ccnc(n1)C(F)(F)F

InChI Key InChIKey=MHMHEAUTLQYUIO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 621885   

TargetSodium channel protein type 8 subunit alpha(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM621885(US20230312528, Example 49B | (S)-N-((R or S)-3- ch...)
Affinity DataIC50: 6.80nMAssay Description:Compounds were tested on human NaV1.8 and NaV1.5 channels stably expressed in human embryo kidney (HEK) 293 cells. Sodium current measurements on Qub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
US Patent